Please assess the completion status of the following clinical trial:

Trial Title: A Research Study to Examine the Difference Between Local Anesthetics Alone and Local Anesthetics Plus Steroids in the Treatment of Chronic Headache

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients, age 18-65 inclusive~* Patients who have chronic daily headache (15 or more headache days per month) for at least 3 months prior to enrollment in the study.~* Headache level should be 5/10 or more at time of GON block.~* Patients should have posterior cervical muscle tenderness at time of nerve block.~Exclusion Criteria:~* Patients who had surgery or any other invasive procedure in the occipital area.~* Patients with abnormal sensory findings on examination or any known neurological disease that may affect skin sensation (peripheral neuropathy, multiple sclerosis, stroke, etc).~* Patients diagnosed with cluster headache~* Patients with skin diseases that may affect skin sensation.~* Patients who are cognitively impaired.~* Patients with significant psychiatric disorder that may affect their understanding of the study protocol and/or their cooperation with the investigators.~* Patients who are pregnant or breast-feeding.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine 2%, Bupivicaine 0.5% and saline (Type: ACTIVE_COMPARATOR): Adult patients with CDH, and headache of at least moderate intensity at time of treatment, were randomized to receive bilateral GONB and trigger point injections in the cervical paraspinal and the trapezius muscles bilaterally.
- Lidocaine 2%, Bupivicaine 0.5% and triamcinolone 40 mg (Type: ACTIVE_COMPARATOR): Adult patients with CDH, and headache of at least moderate intensity at time of treatment, were randomized to receive bilateral GONB and trigger point injections in the cervical paraspinal and the trapezius muscles bilaterally.

Based on this trial design, predict the completion outcome and termination type (if applicable).